Home > Healthcare > Medical Devices > Therapeutic Devices > Stents Market

Stents Market Size

  • Report ID: GMI3372
  • Published Date: Mar 2024
  • Report Format: PDF

Stents Market Size

Stents Market size accounted for revenue of USD 9.4 billion in 2023, expanding at 4.7% CAGR to reach USD 14 billion by 2032. High growth of the market is attributable to increasing adoption of minimally invasive techniques, increasing cardiovascular surgeries, and a hectic lifestyle coupled with rising geriatric population will augment the market growth.

 

Rising adoption of unhealthy habits such as smoking and excessive alcohol usage, increasing consumption of junk food, and advancements in healthcare technology will propel industry growth in the future. Growing cardiovascular disorders and rising demand for minimally invasive procedures will foster the market growth. Moreover, novel developments in drug-eluting stent such as bifurcated stents as well as biodegradable materials, will boost the market value.
 

Stent is a plastic tube inserted into the lumen of an anatomic vessel or duct to keep the passageway open. These stents are often and widely used to treat narrowed coronary arteries that supply the heart with oxygen-rich blood. Moreover, stents are used in procedures or surgeries such as peripheral artery disease (stent replacement), deep vein thrombosis and coronary heart disease (stent placement) among others.
 

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Stents market accounted for revenues worth USD 9.4 billion in 2023, record 4.7% CAGR to reach USD 14.0 billion by 2032, attributed to increasing adoption of minimally invasive techniques and rising number of cardiovascular surgeries.

The vascular stent segment is anticipated to reach USD 13 billion by 2032, driven by the growing burden of coronary artery disease and technological advancements for development of advanced product.

North America stents industry accounted for USD 2.1 billion in 2023 and is projected to record impressive growth through 2032, owing to high prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease.

Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group, Biotronik SE & Co. KG, Boston Scientific Corporation, Becton, Dickinson and Company, Elixir Medical Corporation, Medtronic Plc, Meril Life Science, MicroPort Scientific Corporation, and Stryker Corporation.

Stents Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 718
  • Countries covered: 20
  • Pages: 300
 Download Free Sample